JHS Svendgaard Laboratories Ltd

For the fifth consecutive session, JHS Svendgaard Laboratories Ltd has closed lower, hitting a fresh 52-week low of Rs 6.15 on 30 Mar 2026, marking a steep decline from its 52-week high of Rs 16.20.

Despite a broadly positive market environment, JHS Svendgaard Laboratories Ltd has plunged to a fresh 52-week low of Rs 6.4 on 27 Mar 2026, extending its downward trajectory amid persistent selling pressure.

A sharp decline in JHS Svendgaard Laboratories Ltd has pushed the stock to a fresh 52-week low of Rs 7.12 on 23 Mar 2026, marking a 10.44% drop on the day and extending a downward trend that has seen the share price fall by nearly 42% over the past year. This underperformance stands in stark contrast to the broader market, with the Sensex down just 4.93% over the same period.

Despite a broadly positive market environment, JHS Svendgaard Laboratories Ltd has plunged to a fresh 52-week low of Rs 7.9 on 20 Mar 2026, marking a 52.0% decline from its peak of Rs 16.46 over the past year. This sharp underperformance contrasts starkly with the Nifty's modest gains and highlights persistent headwinds facing the micro-cap FMCG player.

JHS Svendgaard Laboratories Ltd, a micro-cap player in the FMCG sector, recorded a new 52-week low of Rs.7.92 today, marking a significant decline in its stock price amid ongoing market pressures and company-specific challenges.

JHS Svendgaard Laboratories Ltd has reached a new 52-week low of Rs.8 today, marking a significant decline in its stock price amid continued underperformance relative to its sector and benchmark indices.

JHS Svendgaard Laboratories Ltd has touched a new 52-week low of Rs.8.17 today, marking a significant decline in its stock price amid continued underperformance in the FMCG sector. The stock has been on a downward trajectory for the past three days, losing 9.03% in returns during this period and underperforming its sector by 0.71% today.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

JHS Svendgaard Laboratories Ltd has touched a new 52-week low of Rs.8.55 today, marking a significant decline in its stock price amid broader market weakness and persistent underperformance relative to its sector and benchmark indices.

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 Nov 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

JHS Svendgaard Laboratories Ltd has touched a fresh 52-week low of Rs.8.95 today, marking a significant decline in its share price amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on the company’s financial metrics and market sentiment.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

JHS Svendgaard Laboratories Ltd., a micro-cap oral care products manufacturer, reported a net loss of ₹0.20 crores in Q2 FY26 (Jul-Sep'25), reversing from a profit of ₹1.06 crores in the previous quarter. The company's stock, currently trading at ₹10.80, has declined 2.96% following the results announcement and remains down 40.46% over the past year, significantly underperforming the FMCG sector's 4.92% gain. With a market capitalisation of just ₹99.00 crores and a troubling financial track record, the Himachal Pradesh-based manufacturer faces mounting challenges in restoring investor confidence.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 November 2024. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 10 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook.

JHS Svendgaard Laboratories Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 13 November 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 January 2026, providing investors with an up-to-date view of the company's performance and outlook.

JHS Svendgaard Laboratories Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Nov 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 19 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.